论文信息 - Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies. - 字舞流文

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies.

H. Kantarjian | J. Cortes | A. Quintás-Cardama | S. Verstovsek | F. Ravandi | E. Jabbour | S. Strom | S. O'brien | M. Rios | D. Verma | A. Quintás-Cardama